📈 Live Market Tracking
Every NSE and BSE corporate filing, read and explained by AI within minutes — impact, key figures, short/long-term view and what to watch.
Live · AI analyzer runs every 5 min (07:00–23:55 IST)
0 analysed today
FollowTelegram
0
Today
152,139
All-time analysed
43,645
Positive
6,747
Negative
92,898
Neutral
8,781
Watch
📊 Last 7 days — analysed filings by sentiment
Note: These are AI-generated, educational summaries of public NSE
filings — grounded in each document, but not investment advice and possibly incomplete.
Verify against the original filing and consult a SEBI-registered adviser before acting.
520 announcements match the current filters (relevance ≥ 5).
Thyrocare Promoter Docon Technologies Reports 60.93% Total Shareholding Pledged in FY26 Disclosure
Docon Technologies, the promoter of Thyrocare, has filed its annual disclosure under SEBI Takeover Regulations for the financial year ended March 31, 2026. The filing confirms that the promoter's entire 60.93% stake in the company remains encumbered. Notable activity during the year included a pledge modification following a 2:1 bonus issue in December 2025, which brought the total pledged shares to 9,69,69,696. This disclosure is a routine compliance measure to ensure transparency regarding promoter share encumbrances.
Key Highlights
Promoter Docon Technologies and API Holdings confirm 60.93% of total share capital is pledged.
A 2:1 bonus issue in December 2025 led to the encumbrance of 6.46 crore additional shares.
The total number of shares under pledge stands at 9,69,69,696 as of March 31, 2026.
The filing confirms no new undisclosed encumbrances were created during the 2025-26 financial year.
👀 What to Watch
Monitor the high promoter pledge (100% of their stake) as a risk factor for potential volatility. No immediate action is needed as this is a routine regulatory confirmation of existing encumbrances.
Share India Q4 PAT Surges 211% to ₹58 Cr; FY26 Revenue Hits ₹1,470 Cr
Share India Securities reported a robust Q4-FY26 with revenue growing 73.7% YoY to ₹415.9 crore and PAT jumping 211.3% to ₹58 crore. For the full year FY26, revenue remained stable at ₹1,470.3 crore, though PAT saw a marginal decline of 1.1% to ₹324.4 crore. The company is successfully transitioning to a fintech-led model, with its uTrade Algos platform reaching over 71,000 subscriptions. A final dividend of ₹0.50 per share was recommended, bringing the total FY26 payout to ₹1.60 per share.
Key Highlights
Q4-FY26 PAT grew 211.3% YoY to ₹580 Mn with EBITDA margins expanding 626 bps to 28.11%
Full-year FY26 revenue reached ₹14,703 Mn with a 6-year revenue CAGR of 37%
MTF AUM stood at ₹4,239 Mn and NBFC AUM at ₹2,653 Mn as of March 31, 2026
Recommended final dividend of ₹0.50 per share, totaling ₹1.60 for the full financial year
Expanding into AIF, PMS, and fixed-income distribution through newly incorporated subsidiaries
👀 What to Watch
The strong Q4 recovery and expansion into high-margin AIF and PMS segments are positive indicators; investors should monitor the adoption rate of the uTrade Algos platform.
Share India Q4 Net Profit Surges 211% YoY to ₹580 Mn; Final Dividend Announced
Share India Securities reported a massive 211.3% YoY jump in Q4 FY26 net profit to ₹580 million, driven by a 73.7% revenue growth. While the full-year FY26 net profit saw a marginal decline of 1.1% to ₹3,244 million, the Q4 performance indicates a strong recovery and growth momentum. The company is aggressively diversifying its portfolio, having recently incorporated subsidiaries for fixed-income distribution and AIF/PMS services. Additionally, the board has recommended a final dividend of ₹0.50 per share.
Key Highlights
Q4 FY26 Revenue grew 73.7% YoY to ₹4,159 Mn, with EBITDA surging 123.2% to ₹1,169 Mn.
Full-year FY26 Net Profit stood at ₹3,244 Mn, a slight 1.1% decline YoY despite a 10.3% rise in EBITDA.
NBFC loan book reached ₹2,653 Mn with quarterly disbursements of ₹995 Mn across 73 branches.
Broking business recorded an average daily turnover of ₹109 Bn for the quarter ended March 2026.
Board recommended a final dividend of ₹0.50 per share on shares with a face value of ₹2.
👀 What to Watch
Investors should focus on the strong Q4 recovery and the company's strategic expansion into AIF and PMS segments which could drive future margins. The stock remains a key play in the technology-driven brokerage and algo-trading space with a healthy dividend yield.
Hindware Home Innovation FY26 Revenue at ₹2,193 Cr; Bathware EBITDA Grows 30% YoY
Hindware Home Innovation reported a consolidated revenue of ₹2,193 crore for FY26, with the core Bathware segment contributing ₹1,520 crore, a 10% YoY growth. The Bathware business showed strong operational efficiency as EBITDA surged 30% YoY to ₹157 crore, with margins expanding from 8.8% to 10.3%. The company is progressing with a major corporate restructuring to demerge its Consumer Products business into HHIL Limited and amalgamate the rest into Hindware Limited, aiming to unlock stakeholder value. Management has issued a positive outlook for FY27, targeting 15-20% sales growth in the Bathware segment.
Key Highlights
Consolidated FY26 revenue stood at ₹2,193 crore with an improved EBITDA margin of 9%.
Bathware segment revenue grew 10% to ₹1,520 crore, while its EBITDA jumped 30% to ₹157 crore.
Net bank debt was reduced to ₹664 crore in FY26 from ₹693 crore in the previous year.
The company targets a 15-20% sales growth for the Bathware business in FY27.
Composite Scheme of Arrangement for demerger and separate listing of business units has received stock exchange approvals and is pending with NCLT.
👀 What to Watch
Investors should track the NCLT approval process for the demerger, which is expected to unlock value through separate listings. The significant margin expansion in the Bathware segment and the guidance for 15-20% growth in FY27 suggest strong fundamental momentum.
Share India Securities Recommends Re. 0.50 Dividend and Early Redemption of 9,990 NCDs
Share India Securities has announced its audited financial results for the fiscal year ended March 31, 2026, alongside a final dividend recommendation of Re. 0.50 per share. A significant highlight is the board's approval for the early redemption of 9,990 secured, listed Non-Convertible Debentures (NCDs) issued in June 2025. This move to retire debt early suggests a strong liquidity position and intent to reduce interest burdens. The auditors have provided an unmodified opinion on the financial statements, indicating healthy reporting standards.
Key Highlights
Recommended a final dividend of Re. 0.50 per equity share (25% of face value Rs. 2)
Approved early redemption of 9,990 Secured, Listed, Rated, Taxable NCDs
Redemption includes 5,000 Series A and 4,990 Series B debentures issued on June 23, 2025
Auditors issued an unmodified opinion for both Standalone and Consolidated FY26 results
Confirmed full compliance with security cover and utilization of NCD proceeds
👀 What to Watch
Investors should take the early debt redemption as a positive signal of cash surplus and balance sheet strength. The dividend provides a modest yield, but the focus should remain on the company's operational growth in the brokerage and fintech space.
Share India Securities Recommends ₹0.50 Final Dividend; To Redeem 9,990 NCDs Early
Share India Securities has recommended a final dividend of ₹0.50 per equity share for the financial year ended March 31, 2026. In a move to optimize its capital structure, the board also approved the early redemption of 9,990 Secured Non-Convertible Debentures (NCDs) issued in June 2025. This redemption includes 5,000 units of Series A and 4,990 units of Series B debentures. The company also reported its audited financial results for FY26 with an unmodified audit opinion, signaling stable financial reporting.
Key Highlights
Recommended a final dividend of ₹0.50 per equity share on a face value of ₹2.
Approved early redemption of 9,990 Secured, Listed, Rated, Taxable NCDs.
NCD redemption covers 5,000 Series A and 4,990 Series B units issued on June 23, 2025.
Audited standalone and consolidated financial results for FY26 approved with unmodified opinion.
Confirmed security cover and utilization of proceeds for NCDs as of March 31, 2026.
👀 What to Watch
Investors should take the early debt redemption as a positive sign of liquidity and the dividend as a steady yield; maintain a positive outlook on the stock.
Share India Reports FY26 Results, ₹0.50 Final Dividend & Early Redemption of 9,990 NCDs
Share India Securities has approved its audited financial results for the quarter and fiscal year ended March 31, 2026, with an unmodified audit opinion. The Board recommended a final dividend of ₹0.50 per equity share (25% of face value). Notably, the company approved the early redemption of 9,990 secured Non-Convertible Debentures (NCDs) issued in June 2025. This move to retire debt ahead of schedule indicates a strong liquidity position and a focus on reducing interest costs.
Key Highlights
Recommended a final dividend of ₹0.50 per equity share with a face value of ₹2 each
Approved early redemption of 9,990 Secured, Rated, Taxable NCDs (5,000 Series A and 4,990 Series B)
Statutory auditors issued an unmodified opinion for both standalone and consolidated FY26 results
Confirmed zero deviation or variation in the utilization of NCD issue proceeds
The Board meeting concluded with the approval of the full-year audited financial statements
👀 What to Watch
Investors should view the early debt redemption and dividend recommendation as signs of financial health; however, they should review the detailed P&L for operational growth metrics.
Hindware Home Innovation FY26: Revenue Flat at ₹2,510 Cr, Net Loss Narrows to ₹39.3 Cr, No Dividend
Hindware Home Innovation reported a marginal 0.5% decline in consolidated revenue to ₹2,510.28 crore for the financial year ended March 31, 2026. While the company remained loss-making with a net loss of ₹39.31 crore, this was a significant narrowing from the ₹68.77 crore loss reported in FY25. Operational performance showed strength as EBITDA grew 26.7% to ₹232.52 crore, though bottom-line results were weighed down by ₹52.58 crore in exceptional items. Due to the continued losses, the Board has not recommended any dividend for FY26.
Key Highlights
Consolidated Revenue for FY26 stood at ₹2,510.28 crore versus ₹2,522.99 crore in FY25.
EBITDA increased significantly to ₹232.52 crore from ₹183.55 crore in the previous year.
Net loss narrowed to ₹39.31 crore compared to a loss of ₹68.77 crore in FY25.
Building Products segment contributed ₹2,193.40 crore in revenue with an EBIT of ₹117 crore.
Consumer Appliances segment reported an EBIT loss of ₹1.27 crore on revenue of ₹318.07 crore.
👀 What to Watch
Investors should focus on the improving EBITDA margins and the narrowing net loss, while monitoring the turnaround progress in the Consumer Appliances segment. The decision to skip dividends reflects a need to conserve capital amidst ongoing restructuring or exceptional costs.
Hindware Home Innovation FY26: EBITDA Grows 27% to ₹233 Cr; Reports Net Loss of ₹39 Cr
Hindware Home Innovation reported a marginal 0.5% decline in consolidated revenue to ₹2,510.28 crore for FY26. Despite the revenue stagnation, EBITDA saw healthy growth of 26.7%, rising to ₹232.52 crore from ₹183.55 crore in the previous year. However, the company reported a consolidated net loss of ₹39.31 crore, though this was an improvement over the ₹68.77 crore loss in FY25. The board has decided not to recommend any dividend for the fiscal year.
Key Highlights
Consolidated Revenue from operations stood at ₹2,510.28 crore for FY26, down slightly from ₹2,522.99 crore in FY25.
EBITDA from continuing operations increased significantly to ₹232.52 crore compared to ₹183.55 crore in the prior year.
Reported a consolidated net loss of ₹39.31 crore for FY26, impacted by exceptional items totaling ₹52.58 crore.
Building products segment revenue grew to ₹2,193.40 crore, while the consumer appliances segment saw a decline to ₹318.07 crore.
The Board did not recommend any dividend for the financial year ended March 31, 2026.
👀 What to Watch
Investors should monitor the company's ability to translate strong EBITDA growth into bottom-line profitability by managing exceptional costs. The improvement in operating margins is positive, but the lack of top-line growth in the consumer appliances segment warrants a cautious outlook.
Hindware Home Innovation FY26 Revenue at ₹2,510 Cr; Net Loss Narrows to ₹39.3 Cr
Hindware Home Innovation reported a marginal 0.5% decline in annual consolidated revenue to ₹2,510.28 crore for FY26. Despite the revenue dip, the company significantly improved its EBITDA to ₹232.52 crore, up from ₹183.55 crore in the previous year. The consolidated net loss for the year narrowed to ₹39.31 crore compared to a loss of ₹68.77 crore in FY25, though results were impacted by exceptional items of ₹52.58 crore. The board has decided not to recommend any dividend for the financial year ended March 31, 2026.
Key Highlights
Consolidated FY26 revenue stood at ₹2,510.28 crore versus ₹2,522.99 crore in FY25.
EBITDA from continuing operations grew by 26.7% YoY to ₹232.52 crore.
Net loss for the year narrowed significantly to ₹39.31 crore from a loss of ₹68.77 crore in the previous fiscal.
Building products segment remained the primary driver with revenue of ₹2,193.40 crore and segment profit of ₹117 crore.
The Board did not recommend any dividend for FY26 and appointed Shashvat Somany as an Additional Director.
👀 What to Watch
Investors should monitor the operational turnaround as EBITDA margins improve despite stagnant revenue growth. The narrowing net loss is a positive sign, but the company needs to achieve bottom-line profitability and address losses in the consumer appliances segment.
Religare Enterprises FY26 Income Hits ₹8,493 Cr; Announces Demerger for Health Insurance Focus
Religare Enterprises reported a consolidated total income of ₹8,493 crores for FY26, driven by its health insurance subsidiary, Care Health, which crossed the ₹10,000 crore GWP milestone. The company has approved a demerger to separate its lending and broking businesses into Religare Finvest (RFL), leaving REL as a pure-play health insurance holding company. The Burman Group has increased its stake to 30.3% and committed ₹750 crores in capital. While the insurance segment remains robust with a 24% growth in GWP, the housing finance segment reported a loss of ₹18.6 crores for the year.
Key Highlights
Consolidated total income for FY26 reached ₹8,493 crores with a reported PAT of ₹73.16 crores.
Care Health Insurance GWP grew 24% to ₹11,417 crores, with retail health growing at 34%.
Approved demerger will provide shareholders 1 share of RFL for every 1 share of REL held to unlock value.
Religare Finvest (RFL) reported a profit of ₹89 crores in Q4 FY26 with ₹591 crores in cash reserves.
Promoter (Burman Group) stake increased to 30.3% following a ₹750 crore capital commitment.
👀 What to Watch
Investors should consider the demerger as a significant value-unlocking event for the high-growth health insurance business. Monitor the progress of regulatory approvals for the demerger and the stabilization of the housing finance subsidiary.
Waaree Renewable Bags 350MW/1400MWh BESS EPC Order from Group Company
Waaree Renewable Technologies has secured a major turnkey EPC contract for a 350MW/1400MWh Battery Energy Storage System (BESS). The project includes two years of operation and maintenance services and is scheduled for completion within the financial year 2026-27. While the order is from a group entity, Waaree Forever Energies Private Limited, it is stated to be on an arm's length basis. This win significantly strengthens the company's portfolio in the high-growth energy storage segment.
Key Highlights
Turnkey EPC contract for a massive 350MW/1400MWh grid-connected BESS project
Includes 2 years of comprehensive operation and maintenance (O&M) services
Project execution is slated for completion during the financial year 2026-27
Contract awarded by domestic group entity Waaree Forever Energies Private Limited
👀 What to Watch
Investors should view this as a positive expansion into the energy storage market, though they should monitor execution timelines and the margins associated with related-party contracts.
Waaree Energies Subsidiary Acquires 100% Stake in Waaree Semicon for INR 1 Lakh
Waaree Energies' subsidiary, Waaree Power Private Limited, has completed the acquisition of a 100% equity stake in Waaree Semicon Private Limited. The transaction was finalized for a nominal cash consideration of INR 1 lakh. Consequently, Waaree Semicon has become a step-down subsidiary of the company as of May 15, 2026. This acquisition marks a strategic move for the group into the semiconductor domain, although the current financial outlay is minimal.
Key Highlights
Acquisition of 100% equity stake in Waaree Semicon Private Limited.
Total cash consideration for the deal is INR 1 lakh.
Waaree Semicon is now a step-down subsidiary of Waaree Energies.
The acquisition was completed on May 15, 2026, following an April 29 disclosure.
👀 What to Watch
Investors should track the company's roadmap for the semiconductor business, as this small-ticket acquisition likely serves as a vehicle for future expansion. The immediate financial impact is negligible, but the strategic intent is noteworthy.
Waaree Energies to Seek Shareholder Approval for ₹10,000 Crore Fundraise via QIP
Waaree Energies has issued a postal ballot notice to seek shareholder approval for a massive capital raise of up to ₹10,000 crores through a Qualified Institutions Placement (QIP). The company is also seeking the formal appointment of Mr. Jignesh Devchandbhai Rathod as Whole-Time Director and CEO for a five-year term effective March 21, 2026. The e-voting period for these resolutions is set from May 15, 2026, to June 13, 2026. This significant capital infusion indicates the company's intent for aggressive expansion or strengthening its balance sheet in the competitive solar energy sector.
Key Highlights
Proposed capital raise of up to ₹10,000 crores through Qualified Institutions Placement (QIP)
Appointment of Jignesh Devchandbhai Rathod as Whole-Time Director and CEO for a 5-year tenure
E-voting period for shareholders scheduled from May 15, 2026, to June 13, 2026
The fundraise may involve Equity Shares or other eligible convertible securities in one or more tranches
👀 What to Watch
Investors should watch for the specific utilization plan of the ₹10,000 crore fundraise, as it signals major growth but will result in equity dilution. Monitor the new CEO's strategic roadmap for the company's next phase of expansion.
Saregama Q4 Net Profit Rises 24% to ₹74 Cr; FY26 Music Segment Revenue Grows 9%
Saregama reported a strong Q4 FY26 with consolidated net profit rising 23.8% YoY to ₹74.14 crore. While full-year FY26 revenue declined to ₹984.62 crore from ₹1,171.36 crore in FY25, this was primarily due to a sharp contraction in the volatile Events segment. The core Music segment showed resilience, with annual revenue growing 9.4% to ₹683.52 crore. Overall annual profitability remained stable with a net profit of ₹206.22 crore and a slight improvement in EPS to ₹10.73.
Key Highlights
Q4 FY26 consolidated net profit increased to ₹74.14 crore vs ₹59.86 crore in Q4 FY25.
Full-year FY26 revenue from operations stood at ₹984.62 crore, down from ₹1,171.36 crore in FY25.
Music segment annual revenue grew to ₹683.52 crore, contributing the bulk of segment results at ₹364.09 crore.
Events segment revenue saw a significant drop to ₹61.83 crore in FY26 from ₹285.23 crore in the previous year.
The Board approved an updated Insider Trading Prohibition Code and authorized KMPs for materiality disclosures.
👀 What to Watch
Investors should look past the headline revenue decline caused by the low-margin Events business and focus on the steady growth of the high-margin Music IP segment. Monitor the company's ability to scale Artist Management and Video segments as secondary growth drivers.
Saregama Q4 FY26 PAT Rises 24% YoY to ₹74 Cr; Music Segment Grows 9% Annually
Saregama India Limited reported a strong Q4 FY26 with revenue growing 19.4% YoY to ₹287.4 crore and PAT increasing 24% to ₹74.1 crore. However, full-year FY26 revenue declined by 15.9% to ₹984.6 crore, primarily due to a significant contraction in the Events segment, which fell from ₹285.2 crore to ₹61.8 crore. The core Music segment remained resilient, growing 9.4% annually to ₹683.5 crore. Despite the overall revenue dip, full-year profitability remained stable with a PAT of ₹206.2 crore compared to ₹204.2 crore in the previous year.
Key Highlights
Q4 FY26 Revenue from operations increased 19.4% YoY to ₹28,744 Lakhs.
Full-year FY26 PAT stood at ₹20,622 Lakhs, showing marginal growth over FY25's ₹20,424 Lakhs.
Music segment revenue grew to ₹68,352 Lakhs in FY26 from ₹62,484 Lakhs in FY25.
Events segment revenue saw a sharp decline of 78% YoY, falling to ₹6,183 Lakhs for the full year.
The company invested ₹32,516 Lakhs (approx. ₹325 Cr) for the acquisition of an associate during the year.
👀 What to Watch
Investors should look past the headline revenue decline caused by the volatile Events business and focus on the steady growth of the high-margin Music segment. Monitor the integration and returns from the significant ₹325 crore associate acquisition made during the fiscal year.
Saregama Q4 Net Profit Rises 25% YoY to ₹75.4 Cr; Music & Artist Management Lead Growth
Saregama reported a strong Q4 FY26 performance with consolidated revenue growing 19.4% YoY to ₹287.4 crore and net profit increasing 25.4% to ₹75.4 crore. While annual revenue for FY26 saw a decline of 15.9% to ₹984.6 crore compared to FY25, the company maintained profitability with a full-year net profit of ₹207 crore. The Music segment remains the primary driver, contributing ₹200.4 crore in Q4, while the Artist Management segment showed explosive growth of 125% YoY. Despite the annual revenue dip, the company's margin management and recovery in the final quarter provide a positive outlook.
Key Highlights
Q4 FY26 Consolidated Revenue grew 19.4% YoY to ₹287.4 crore compared to ₹240.8 crore in Q4 FY25.
Q4 Net Profit (attributable to owners) increased 25.4% YoY to ₹75.4 crore from ₹60.1 crore.
Artist Management segment revenue surged 125% YoY to ₹42.5 crore in the final quarter.
Full-year FY26 revenue stood at ₹984.6 crore, a 15.9% decline from FY25's ₹1,171.4 crore, primarily due to lower Events and Video revenue.
The company made a significant investment of ₹325.2 crore in an associate during the year, impacting cash balances.
👀 What to Watch
Investors should focus on the strong Q4 recovery and the rapid scaling of the high-margin Artist Management business. While annual revenue dipped, the core Music licensing business remains robust, and the company's ability to maintain profit levels suggests efficient cost management.
Saregama Q4 FY26: Highest Ever Quarterly EBITDA of Rs. 1,327 Mn, Up 31% YoY
Saregama reported a robust Q4 FY26 with revenue growing 19% YoY to Rs. 2,874 Mn and its highest-ever quarterly EBITDA. The core Music segment remains the primary growth engine, with annual revenue increasing 17% to Rs. 8,144 Mn and net margins expanding to 55% in Q4. While Live Events revenue declined 78% due to a high base effect from a major tour in FY25, the company is aggressively investing in new music IP and AI-driven content creation. Management projects a 20-23% CAGR for music revenue over the next 3-5 years.
Key Highlights
Achieved highest ever quarterly Adj. EBITDA of Rs. 1,327 Mn, a 31% YoY increase.
Music segment annual net margin grew by 28% YoY to reach Rs. 3,768 Mn.
Highest ever annual investment in content with Rs. 2,354 Mn in new music and Rs. 1,047 Mn in catalogue purchases.
Digital footprint reached 650 Mn+ followers across YouTube, Instagram, and Facebook.
Live Events revenue fell to Rs. 618 Mn from Rs. 2,852 Mn in FY25 due to the absence of the Diljit Dosanjh India tour.
👀 What to Watch
Investors should view the strong margin expansion in the core music licensing business as a positive indicator of long-term profitability. The company's aggressive IP acquisition strategy and pivot toward AI-driven efficiency provide a solid moat against competitors.
Saregama Q4 FY26: Highest Ever Quarterly EBITDA of Rs. 1,327 Mn, Up 31% YoY
Saregama reported a robust Q4 FY26 with revenue growing 19% YoY to Rs. 2,874 Mn and its highest-ever quarterly EBITDA of Rs. 1,327 Mn. The core Music segment remains the primary driver, with annual revenue growing 17% and net margins expanding to 55% in Q4. While Live Events saw a 78% YoY decline due to a high base effect from the previous year's Diljit Dosanjh tour, the company is diversifying into new IPs like UN40. The company continues aggressive IP investment, spending Rs. 3,401 Mn on new music and catalogue purchases during the year.
Key Highlights
Highest ever quarterly EBITDA of Rs. 1,327 Mn, representing a 31% YoY growth with 19% revenue growth.
Music segment annual revenue grew 17% to Rs. 8,144 Mn with a 28% growth in net margins to Rs. 3,768 Mn.
Aggressive IP acquisition with Rs. 3,401 Mn total investment in new music and catalogues in FY26.
Live Events revenue dropped 78% YoY to Rs. 618 Mn, reflecting the absence of major tours compared to FY25.
Digital reach expanded to 650 Mn+ followers across social platforms with a roster of 300+ artistes.
👀 What to Watch
Investors should focus on the consistent margin expansion in the core music licensing business and the company's aggressive IP acquisition strategy. The shift away from capital-intensive film production towards high-margin music and artiste management strengthens the long-term profitability outlook.
Thyrocare Q4 FY26: Revenue Grows 20% YoY; Specialized Jaanch Segment Surges 66%
Thyrocare reported a robust 21% YoY consolidated revenue growth for FY26, supported by a 23% increase in test volumes to 210 million. The specialized 'Jaanch' segment showed exceptional growth of 66% in Q4, while the flagship 'Aarogyam' brand grew 20%. Despite a slight dip in the partnership segment's Q4 growth to 23% due to a high base effect of INR 4 crore from the previous year, the company expanded its network to 10,800 franchisees and 41 labs globally. Strategic forays into genomics and the African market (Tanzania) signal a shift towards high-margin specialty diagnostics and geographic diversification.
Key Highlights
Consolidated revenue grew 21% YoY in FY26, with Q4 revenue increasing by 20% YoY.
Processed 210 million tests in FY26 (up 23% YoY) and served 19.2 million patients (up 15% YoY).
The specialized 'Jaanch' portfolio surged 66% YoY in Q4, reflecting a shift toward disease-specific testing.
Active franchisee network reached a record 10,800, while the lab network expanded to 41 locations including Tanzania.
Maintained Six Sigma quality levels with complaints reduced to 3.06 per million tests and a turnaround time of 3.43 hours.
👀 What to Watch
Investors should monitor the scaling of the high-margin genomics and specialty segments, which are expected to drive future profitability. The company's expansion into Africa and its dominant B2B partnership growth make it a strong contender in the organized diagnostic space.
